This narrative review examined the evidence and continuing role of strategies for the primary prevention and treatment of obesity, in the context of effective obesity pharmacotherapies. Pharmacotherapies are powerful treatment agents for clinical obesity but must consider nutritional and metabolic risks of use and discontinuation.